SCHEMBL5587186

SCHEMBL5587186

CCCc1c(I)cc(OC(=O)O)c(O)c1CCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 2/20 0.37
LDHB P07195 2/20 0.37
TDP1 Q9NUW8 1/20 0.36
ESR1 P03372 2/20 0.36
SIRT5 Q9NXA8 1/20 0.33
CYSLTR2 Q9NS75 4/20 0.32
CYSLTR1 Q9Y271 4/20 0.32
ALOX5 P09917 1/20 0.32
PPARG P37231 2/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
MAPT P10636 1/20 0.32
CYP2C9 P11712 1/20 0.32
NFKB1 P19838 1/20 0.32
BLM P54132 1/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
GRM2 Q14416 1/20 0.32
ITGB3 P05106 1/20 0.31
ITGAV P06756 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590409 0.91 ESR1 (0.40) TDP1ESR1ALOX5HCAR2TP53
SCHEMBL5586903 0.90 ALOX5 (0.44) ESR1ALOX5PPARGPPARDPPARA
SCHEMBL5589221 0.88 ALOX5 (0.47) ESR1ALOX5PPARGPPARAHCAR2
SCHEMBL5588285 0.88 ALOX5 (0.47) ESR1ALOX5PPARGPPARAHCAR2
SCHEMBL5589948 0.88 ALOX5 (0.47) ESR1ALOX5PPARGPPARAHCAR2
SCHEMBL5587810 0.88 ALOX5 (0.47) ESR1ALOX5PPARGPPARAHCAR2
SCHEMBL5587871 0.88 ALOX5 (0.47) ESR1ALOX5PPARGPPARAHCAR2
SCHEMBL5587163 0.84 TSHR (0.37) LDHALDHBESR1CYSLTR2CYSLTR1
SCHEMBL5588004 0.84 TDP1 (0.38) TDP1ESR1SIRT5PPARGLMNA
SCHEMBL5678273 0.83 LDHA (0.44) LDHALDHBESR1CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LDHA 320/4885LDHB 486/4885TDP1 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.